Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Fischer Medical Ventures Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Fischer Medical Ventures Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Fischer Medical Vent - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2025, 3:52PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Fischer Medical Vent - Announcement Under Regulation 30

    23 Apr 2025, 4:22PM Intimation by Material Subsidiary on the Investment
  • Fischer Medical Vent - Announcement Under Regulation 30 - Intimation Of Receipt Of Central Government Approval

    23 Apr 2025, 3:37PM Fischer Medical Ventures Ltd has informed the exchange on receipt of Central Government Approval for appointment of Managing Director
  • Fischer Medical Vent - Announcement Under Regulation 30

    21 Apr 2025, 8:58PM Update from Material Subsidiary on its proposed investment
  • Fischer Medical Vent - Announcement Under Regulation 30

    21 Apr 2025, 8:55PM Fischer Medical Ventures Limited has informed the exchange on approval for proposed investment as detailed in the annexures to this announcement
  • Fischer Medical Vent - General Update

    10 Apr 2025, 2:42PM Please find attached file
  • Fischer Medical Vent - Update On Allotment Of ISIN

    9 Apr 2025, 7:04PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on creation of ISIN with NSDL
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    9 Apr 2025, 6:30PM Fischer Medical Ventures Limited has allotted 10,50,000 equity shares upon conversion of convertible warrants issued on a preferential basis to non-pr
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    9 Apr 2025, 3:00PM As of March 2025, 62.81% is owned by Promoters and 37.19% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.82% and Fore
  • Fischer Medical Vent - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 2:01PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the compliance of Certificate under Regulatio
  • Fischer Medical Vent - Intimation About Investment By Material Subsidiary

    7 Apr 2025, 7:01PM Intimation about Investment in Material Subsidiary
  • Fischer Medical Vent - Postal Ballot Notice Intimation

    4 Apr 2025, 1:44PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on intimation of Postal Ballot Notice
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Resignation of Director

    27 Mar 2025, 4:56PM Fischer Medical Ventures intimated the exchange on Resignation of Independent Director with additional details as required under the SEBI (LODR) Regul
  • Fischer Medical Vent - Reconstitution Of Committees

    27 Mar 2025, 11:04AM Fischer Medical Ventures Limited has informed the exchange on the reconstitution of Committees of the Board.
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Resignation of Director

    26 Mar 2025, 2:53PM Fischer Medical Ventures Limited has intimated the exchange on the resignation of Independent Director with effect from closing hours of 26th March 20
  • Fischer Medical Vent - Update By Material Subsidiary

    25 Mar 2025, 12:05PM Update by material subsidiary
  • Fischer Medical Vent - Board Meeting Intimation for Change In Independent Director And Other Related And General Corporate Pu

    24 Mar 2025, 2:52PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/03/2025 ,inter alia, to cons
  • Fischer Medical Vent has submitted to BSE the Shareholding Pattern for the Period Ended February 18, 2025

    17 Mar 2025, 5:50PM As of February 2025, 62.82% is owned by Indian Promoters and 37.19% by Public. <p align=justify> Top two Promoters holding highest number of shares of
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Allotment

    4 Mar 2025, 5:29PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the intimation of investment through rights i
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

    4 Mar 2025, 1:55PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the receipt of Certificate from Registrar of
  • Fischer Medical Vent - Integrated Filing (Financial)

    3 Mar 2025, 10:01PM Integrated Financials for the quarter ended 31.12.2024
  • Fischer Medical Vent - Integrated Filing (Financial)

    3 Mar 2025, 4:47PM Fischer Medical Ventures Limited has informed the exchange on the Integrated filing (financials) for the quarter ended 31.12.2024
  • Fischer Medical Vent - Announcement Relating To Proposed Investment Of Funds In Wholly Owned Subsidiary

    26 Feb 2025, 9:32PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on update on approval for proposed investment in
  • Fischer Medical Vent - Update On Receipt Of Disclosure Under Regulation 29(2) Of SEBI (SAST), 2015

    19 Feb 2025, 7:51PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the receipt of Disclosure made by the Promote
  • Fischer Medical Vent - Board Meeting Outcome for Allotment Of Equity Shares And Warrants

    18 Feb 2025, 12:24PM Fischer Medical ventures Limited(Formerly known as Fischer Chemic Limited) as informed the exchange on the outcome of Board meeting held on 18-02-2025
  • Fischer Medical Vent - Announcement Under Regulation 30 - Incorporation Of Subsidiary Company

    15 Feb 2025, 8:45PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the Incorporation of Subsidiary Company
  • Fischer Medical Vent - Board Meeting Outcome for RESULTS - FINANCIAL RESULTS - 31.12.2024

    14 Feb 2025, 7:28PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on unaudited financial results for the quarter e
  • Fischer Medical Vent - Results - Financial Results For 31/12/2024

    14 Feb 2025, 7:25PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the unaudited financial results for the quart
  • Fischer Medical Vent - Announcement Under Regulation 30 - Update On Re- Constitution Of Audit Committee

    12 Feb 2025, 10:43PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the Exchange on outcome of Circular resolution on appointment
  • Fischer Medical Vent - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter

    7 Feb 2025, 6:03PM Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to cons
  • Fischer Medical Vent - Intimation Of Supply Of 10 Nos. Of 1.5T Whole Body MRI Machines To Atrium Diagnostics

    5 Feb 2025, 10:59AM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on supply of 10 Nos. of 1.5T Whole Body MRI Mach
  • Fischer Medical Vent - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    2 Feb 2025, 3:24PM Fischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on Voting results and scrutiniser report in resp
  • Fischer Medical Vent - Announcement under Regulation 30 (LODR)-Meeting Updates

    2 Feb 2025, 3:20PM Fischer Medical Ventures Limited has informed the exchange on the Voting results and scrutinizer report in respect of 1st EGM for the FY 2024 - 2025 c

Key fundamentals

Evaluate the intrinsic value of Fischer Medical Ventures Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 79.6794 0.3057 0.1597 0.2359 0.0787
Liabilities 79.6794 0.3057 0.1597 0.2359 0.0787
Equity 53.5 0.172 0.172 0.172 0.172
Gross Profit -0.1952 0.0152 -0.1887 -0.1825 -0.2069
Net Profit 0.4028 -0.0365 -0.2326 0.1406 -0.041
Cash From Operating Activities 0.0796 -0.1459 -0.1769 -0.0573 0.0119
NPM(%) 3.49 -20.33 0 0 0
Revenue 11.5283 0.1795 0 0 0
Expenses 11.7235 0.1643 0.1887 0.1825 0.2069
ROE(%) 0.44 -0.04 -0.25 0.15 -0.04

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Fischer Medical Ventures Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 778.05 -0.18 41.79 770.51 910.25 0.77
Sharda Cropchem Ltd 546.75 -0.71 20.33 7656.56 35.34 0.55
Ram Minerals and Chemicals Ltd 0.49 0.00 49.00 17464.38 -0.09 0.00
Amines and Plasticizers Ltd 206.90 -2.82 27.85 4669.27 361.94 0.24

Company Info

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

The Company was incorporated as a Public Limited Company on 22nd March 1993, and obtained certificate of commencement of business on 19th August 1993. The Company entered into an agreement with the Partnership firm M/s. Fischer Inorganics & Aromatics, Madras to take over the partnership business as a going concern without any break as per the agreement dated 19th January 1994. To fully exploit the vast potential and growth prospects available for the various grades of laboratory chemicals particularly after the delicensing of the industry,the promoters have thought fit to put up a larger capacity project so as to achieve the economies of scale of production and marketing. The partnership firm has been engaged in the Processing/Manufacturing of Laboratory Grade Chemicals, for about 10 years. PRESENT BUSINESS The Company is already engaged in the manufacture of certain grades of Laboratory Chemicals in its plant situated at Aminjikarai and Palavakkam, near Madras city (taken over from the partnership firm M/s Fischer Inorganics and Aromatics). These Grades of Laboratory Chemicals are broadly clasified as SALTS, SOLVENTS & ACIDS which include 1. Laboratory & Analytical Reagent Grade Chemicals (LR & AR Grade) used in QC/R & D Lab. of Industries / Institutions 2. Electronic Reagent Grade Chemicals (EL Grade) used in the Process of both Manufacturing & Assembling Electronic Industries. 3. IP Grade Chemicals used in Pharmaceutical Industries. 4. Diagnostic Grade Chemicals used in Hospitals/Clinical Laboratories for either Bio-Chemical or Histopathological Estimations. 2003 -Fischer Chem gets ISO 9001:2000 certification by M/s. RWTUV of Germany 2008 -Fischer Chemic has designated E-mail ID for Investors Complaints: fischerlab@vsnl.net 2013 -Company has changed its Registered Office from No. 3/240, Govindan Nagar, Palavakkam, Chennai - 600041, Tamilnadu to First Floor, Silver Sky Super Market Complex, New No. 15 Gangai Amman Koil Street, Kodambakkam, Chennai - 600 024, Tamilnadu.

Read More

Parent Organisation

Fischer Medical Ventures Ltd.

Founded

22/03/1993

Managing Director

Mr.Ravindran Govindan

NSE Symbol

FAQ

The current price of Fischer Medical Ventures Ltd is

The 52-week high for Fischer Medical Ventures Ltd is

The market capitalization of Fischer Medical Ventures Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Fischer Medical Ventures Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Fischer Medical Ventures Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fischer Medical Ventures Ltd shares.

The CEO of Fischer Medical Ventures Ltd is Mr.Ravindran Govindan, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT